{"transactions":[{"id":992299,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-20T07:00:04.000Z","date":"2025-11-18","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":0.3652,"value":2191.2,"ownership":{"direct":true},"balance_after":241001,"source":{"system":"sec-edgar","filing":"0001193125-25-288848","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000119312525288848/ownership.xml","form_type":"4"}},{"id":1068609,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-12T07:00:06.000Z","date":"2025-08-08","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":0.7236,"value":10854.0,"ownership":{"direct":true},"balance_after":235001,"source":{"system":"sec-edgar","filing":"0000950170-25-106908","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000095017025106908/ownership.xml","form_type":"4"}},{"id":1435777,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-08-12T09:00:05.000Z","date":"2024-08-06","kind":"exercise","planned":false,"acquired":true,"shares":106247,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased in the Issuer's rights offering (the \"Offering\") which closed on August 9, 2024. As part of the Offering, the Reporting Person purchased 106,247 units at a subscription price of $1.21 per whole unit. Each unit consisted of (a) one ordinary share, (b) a warrant to purchase 0.50 ordinary shares, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration one year from the date of issuance (\"1-year warrants\"), and (c) a warrant to purchase one ordinary share, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration five years from the date of issuance (\"5-year warrants\")."}],"balance_after":106247,"derivative":{"exercise_price":1.21,"exercise_date":"2024-08-09","expiration_date":"2029-08-09","underlying":"Ordinary Shares","underlying_shares":106247},"source":{"system":"sec-edgar","filing":"0000950170-24-095096","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000095017024095096/ownership.xml","form_type":"4"}},{"id":1435776,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2024-08-12T09:00:05.000Z","date":"2024-08-06","kind":"exercise","planned":false,"acquired":true,"shares":106247,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased in the Issuer's rights offering (the \"Offering\") which closed on August 9, 2024. As part of the Offering, the Reporting Person purchased 106,247 units at a subscription price of $1.21 per whole unit. Each unit consisted of (a) one ordinary share, (b) a warrant to purchase 0.50 ordinary shares, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration one year from the date of issuance (\"1-year warrants\"), and (c) a warrant to purchase one ordinary share, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration five years from the date of issuance (\"5-year warrants\")."}],"balance_after":106247,"derivative":{"exercise_price":1.21,"exercise_date":"2024-08-09","expiration_date":"2025-08-09","underlying":"Ordinary Shares","underlying_shares":53123},"source":{"system":"sec-edgar","filing":"0000950170-24-095096","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000095017024095096/ownership.xml","form_type":"4"}},{"id":1435775,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Subscription Rights (right to buy)","published_at":"2024-08-12T09:00:05.000Z","date":"2024-08-06","kind":"exercise","planned":false,"acquired":false,"shares":212494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The Reporting Person validly exercised 212,494 subscription rights to acquire 106,247 units composed of (i) 106,247 ordinary shares, (ii) 106,247 1-year warrants and (iii) 106,247 5-year warrants."}],"balance_after":0,"derivative":{"exercise_price":0.61,"exercise_date":"2024-07-22","expiration_date":"2024-08-06","underlying":"Units"},"source":{"system":"sec-edgar","filing":"0000950170-24-095096","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000095017024095096/ownership.xml","form_type":"4"}},{"id":1435774,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-12T09:00:05.000Z","date":"2024-08-06","kind":"exercise","planned":false,"acquired":true,"shares":106247,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased in the Issuer's rights offering (the \"Offering\") which closed on August 9, 2024. As part of the Offering, the Reporting Person purchased 106,247 units at a subscription price of $1.21 per whole unit. Each unit consisted of (a) one ordinary share, (b) a warrant to purchase 0.50 ordinary shares, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration one year from the date of issuance (\"1-year warrants\"), and (c) a warrant to purchase one ordinary share, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration five years from the date of issuance (\"5-year warrants\")."}],"balance_after":220001,"source":{"system":"sec-edgar","filing":"0000950170-24-095096","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000095017024095096/ownership.xml","form_type":"4"}},{"id":1699358,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-12-27T09:00:06.000Z","date":"2023-12-22","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.4,"value":35000.0,"ownership":{"direct":true},"balance_after":113754,"source":{"system":"sec-edgar","filing":"0001209191-23-059750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123059750/doc4.xml","form_type":"4"}},{"id":1704385,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-12-19T16:15:25.000Z","date":"2023-12-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.8442,"value":18442.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  The securities were purchased in multiple transactions at per share prices ranging from $1.795 to $1.85.  The Reporting Person undertakes to provide upon request of the SEC staff, the Issuer, or any shareholder of the Issuer, full information requiring the number of securities purchased at each separate price within the range set forth in this footnote."}],"balance_after":88754,"source":{"system":"sec-edgar","filing":"0001209191-23-059133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123059133/doc4.xml","form_type":"4"}},{"id":1729368,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-11-27T17:00:19.000Z","date":"2023-11-22","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.0345,"value":40690.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.93 to $2.11. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote."}],"balance_after":78754,"source":{"system":"sec-edgar","filing":"0001209191-23-056685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123056685/doc4.xml","form_type":"4"}},{"id":1770139,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-10-02T09:20:18.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":false,"shares":3487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 23, 2022, the reporting person was granted an award of 3,487 RSUs, which vested in full on October 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 23, 2022, the reporting person was granted an award of 3,487 RSUs, which vested in full on October 1, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3487},"source":{"system":"sec-edgar","filing":"0001209191-23-050911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123050911/doc4.xml","form_type":"4"}},{"id":1770138,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-10-02T09:20:18.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":true,"shares":3487,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."}],"balance_after":58754,"source":{"system":"sec-edgar","filing":"0001209191-23-050911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123050911/doc4.xml","form_type":"4"}},{"id":1839334,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-07-03T08:00:07.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":false,"shares":1779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 25, 2022, the reporting person was granted an award of 1,799 RSUs, which vested in full on July 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 25, 2022, the reporting person was granted an award of 1,799 RSUs, which vested in full on July 1, 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1779},"source":{"system":"sec-edgar","filing":"0001209191-23-040406","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123040406/doc4.xml","form_type":"4"}},{"id":1839333,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-07-03T08:00:07.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":true,"shares":1779,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."}],"balance_after":55267,"source":{"system":"sec-edgar","filing":"0001209191-23-040406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123040406/doc4.xml","form_type":"4"}},{"id":1853911,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-06-15T17:00:12.000Z","date":"2023-06-15","kind":"exercise","planned":false,"acquired":false,"shares":15853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 15, 2022, the reporting person was granted an award of 15,853 RSUs, which vested in full on June 15, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 15, 2022, the reporting person was granted an award of 15,853 RSUs, which vested in full on June 15, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the \"Reverse Share Split\").  The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15853},"source":{"system":"sec-edgar","filing":"0001209191-23-037407","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123037407/doc4.xml","form_type":"4"}},{"id":1853910,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-15T17:00:12.000Z","date":"2023-06-15","kind":"exercise","planned":false,"acquired":true,"shares":15853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."}],"balance_after":53488,"source":{"system":"sec-edgar","filing":"0001209191-23-037407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123037407/doc4.xml","form_type":"4"}},{"id":1866243,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-05T08:00:07.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":true,"shares":1299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed solely to correct an error in the Amount of Securities Beneficially Owned Following Reported Transaction in the original Form 4, as filed on April 3, 2023. The Amount of Securities Beneficially Owned Following Reported Transaction on April 1, 2023, which were reported as 37,636, should have been reported as 37,635."}],"balance_after":37635,"source":{"system":"sec-edgar","filing":"0001209191-23-034106","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123034106/doc4a.xml","form_type":"4/A","original_submission_date":"2023-04-03"}},{"id":1931933,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-04-03T20:00:11.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":false,"shares":1299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 25, 2022, the reporting person was granted an award of 1,299 RSUs, which vested in full on April 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 25, 2022, the reporting person was granted an award of 1,299 RSUs, which vested in full on April 1, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the \"Reverse Share Split\").  The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1299},"source":{"system":"sec-edgar","filing":"0001209191-23-022422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123022422/doc4.xml","form_type":"4"}},{"id":1931932,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-04-03T20:00:11.000Z","date":"2023-04-01","kind":"exercise","planned":false,"acquired":true,"shares":1299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."}],"balance_after":37636,"source":{"system":"sec-edgar","filing":"0001209191-23-022422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123022422/doc4.xml","form_type":"4"}},{"id":2065886,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-01-04T18:00:23.000Z","date":"2023-01-01","kind":"exercise","acquired":false,"shares":761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 25, 2022, the reporting person was granted an award of 11,426 RSUs (the \"RSU Grant\"), which vested on January 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 25, 2022, the reporting person was granted an award of 11,426 RSUs (the \"RSU Grant\"), which vested on January 1, 2023."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the \"Reverse Share Split\"). The number of ordinary shares underlying the RSU Grant have been adjusted to reflect the Reverse Share Split."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":761},"source":{"system":"sec-edgar","filing":"0001209191-23-001287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123001287/doc4.xml","form_type":"4"}},{"id":2065885,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-01-04T18:00:23.000Z","date":"2023-01-01","kind":"exercise","acquired":true,"shares":761,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."}],"balance_after":36337,"source":{"system":"sec-edgar","filing":"0001209191-23-001287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919123001287/doc4.xml","form_type":"4"}},{"id":2075413,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-12-28T21:00:13.000Z","date":"2022-12-23","kind":"grant","acquired":true,"shares":3487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit (\"RSU\") represents the contingent right to receive one ordinary share upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the RSUs shall vest in full on October 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the RSUs shall vest in full on October 1, 2023."}],"balance_after":3487,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3487},"source":{"system":"sec-edgar","filing":"0001209191-22-062871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919122062871/doc4.xml","form_type":"4"}},{"id":2150404,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-09-27T21:00:40.000Z","date":"2022-09-25","kind":"grant","acquired":true,"shares":1779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit (\"RSU\") represents the contingent right to receive one ordinary share upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the RSUs shall vest in full on July 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the RSUs shall vest in full on July 1, 2023."}],"balance_after":1779,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1779},"source":{"system":"sec-edgar","filing":"0001209191-22-051416","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919122051416/doc4.xml","form_type":"4"}},{"id":2162015,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-09-09T18:00:23.000Z","date":"2022-09-07","kind":"purchase","acquired":true,"shares":10000,"price":2.22,"value":22200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the \"Reverse Share Split\").  The number of ordinary shares reported on this Form 4 have been adjusted to reflect the Reverse Share Split."}],"balance_after":35576,"source":{"system":"sec-edgar","filing":"0001209191-22-049352","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919122049352/doc4.xml","form_type":"4"}},{"id":2219996,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-06-28T21:00:15.000Z","date":"2022-06-25","kind":"grant","acquired":true,"shares":19488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit (\"RSU\") represents the contingent right to receive one ordinary share upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the RSUs shall vest in full on April 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the RSUs shall vest in full on April 1, 2023."}],"balance_after":19488,"derivative":{"underlying":"Ordinary Shares","underlying_shares":19488},"source":{"system":"sec-edgar","filing":"0001209191-22-039706","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919122039706/doc4.xml","form_type":"4"}},{"id":2221827,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-06-24T18:00:19.000Z","date":"2022-06-23","kind":"exercise","acquired":false,"shares":36798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 23, 2021, the reporting person was granted an award of 36,798 RSUs, which vested on June 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 23, 2021, the reporting person was granted an award of 36,798 RSUs, which vested on June 23, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":36798},"source":{"system":"sec-edgar","filing":"0001209191-22-039312","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919122039312/doc4.xml","form_type":"4"}},{"id":2221826,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-24T18:00:19.000Z","date":"2022-06-23","kind":"exercise","acquired":true,"shares":36798,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units (\"RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs."}],"balance_after":383647,"source":{"system":"sec-edgar","filing":"0001209191-22-039312","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919122039312/doc4.xml","form_type":"4"}},{"id":2227062,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-06-17T17:00:52.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":237795,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit (\"RSU\") represents the contingent right to receive one ordinary share upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the RSUs shall vest in full on June 15, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the RSUs shall vest in full on June 15, 2023."}],"balance_after":237795,"derivative":{"underlying":"Ordinary Shares","underlying_shares":237795},"source":{"system":"sec-edgar","filing":"0001209191-22-037937","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919122037937/doc4.xml","form_type":"4"}},{"id":2314958,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-03-29T20:00:14.000Z","date":"2022-03-25","kind":"grant","acquired":true,"shares":11426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit (\"2022 RSU\") represents the contingent right to receive one ordinary share upon vesting of a 2022 RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the 2022 RSUs shall vest in full on January 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the 2022 RSUs shall vest in full on January 1, 2023."}],"balance_after":11426,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11426},"source":{"system":"sec-edgar","filing":"0001209191-22-021542","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919122021542/doc4.xml","form_type":"4"}},{"id":2314957,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-03-29T20:00:14.000Z","date":"2022-03-25","kind":"exercise","acquired":false,"shares":10494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted share units (\"2021 RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the 2021 RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 25, 2021, the reporting person was granted an award of 10,494 2021 RSUs, which vested on March 25, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 25, 2021, the reporting person was granted an award of 10,494 2021 RSUs, which vested on March 25, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10494},"source":{"system":"sec-edgar","filing":"0001209191-22-021542","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919122021542/doc4.xml","form_type":"4"}},{"id":2314956,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-03-29T20:00:14.000Z","date":"2022-03-25","kind":"exercise","acquired":true,"shares":10494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units (\"2021 RSUs\") converted into ordinary shares on a one-for-one basis upon vesting of the 2021 RSUs."}],"balance_after":346849,"source":{"system":"sec-edgar","filing":"0001209191-22-021542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919122021542/doc4.xml","form_type":"4"}},{"id":2623649,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-07-27T21:30:14.000Z","date":"2021-07-25","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 80,000 ordinary shares received upon vesting of performance-based stock units (\"PSUs\") on July 25, 2021, which PSUs were subject to performance conditions that have been satisfied. PSUs convert into ordinary shares on a one-for-one basis."}],"balance_after":336355,"source":{"system":"sec-edgar","filing":"0000899243-21-030223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000089924321030223/doc4.xml","form_type":"4"}},{"id":2654453,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-25T16:05:44.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":36798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit (\"RSU\") represents the contingent right to receive one ordinary share upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the RSUs shall vest in full on June 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the RSUs shall vest in full on June 23, 2022."}],"balance_after":36798,"derivative":{"underlying":"Ordinary Shares","underlying_shares":36798},"source":{"system":"sec-edgar","filing":"0000899243-21-025953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000089924321025953/doc4.xml","form_type":"4"}},{"id":2769064,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-03-29T17:33:25.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":10494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit (\"RSU\") represents the contingent right to receive one ordinary share upon vesting of the RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, the RSUs shall vest on March 25, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, the RSUs shall vest on March 25, 2022."}],"balance_after":10494,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10494},"source":{"system":"sec-edgar","filing":"0000899243-21-013822","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000089924321013822/doc4.xml","form_type":"4"}},{"id":2893228,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-01-27T19:32:23.000Z","date":"2021-01-26","kind":"sale","acquired":false,"shares":33143,"price":1.73,"value":57337.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the PSUs. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":256355,"source":{"system":"sec-edgar","filing":"0000899243-21-003519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000089924321003519/doc4.xml","form_type":"4"}},{"id":2893227,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-01-27T19:32:23.000Z","date":"2021-01-25","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 80,000 ordinary shares received upon vesting of performance-based stock units (\"PSUs\") on January 25, 2021, which PSUs were subject to performance conditions that have been satisfied. PSUs convert into ordinary shares on a one-for-one basis."}],"balance_after":289498,"source":{"system":"sec-edgar","filing":"0000899243-21-003519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000089924321003519/doc4.xml","form_type":"4"}},{"id":2998520,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Warrants (right to buy)","published_at":"2020-10-28T16:15:09.000Z","date":"2020-10-27","kind":"purchase","acquired":true,"shares":46155,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased in the Issuer's registered public offering on October 27, 2020 at a combined purchase price of $0.65 per ordinary share and warrant. Each ordinary share was purchased together with a warrant to purchase 0.75 of an ordinary share."}],"balance_after":46155,"derivative":{"exercise_price":0.65,"exercise_date":"2020-10-27","expiration_date":"2025-10-27","underlying":"Ordinary Shares","underlying_shares":46155},"source":{"system":"sec-edgar","filing":"0000899243-20-029501","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000089924320029501/doc4.xml","form_type":"4"}},{"id":2998519,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2020-10-28T16:15:09.000Z","date":"2020-10-27","kind":"purchase","acquired":true,"shares":61540,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were purchased in the Issuer's registered public offering on October 27, 2020 at a combined purchase price of $0.65 per ordinary share and warrant. Each ordinary share was purchased together with a warrant to purchase 0.75 of an ordinary share."}],"balance_after":209498,"source":{"system":"sec-edgar","filing":"0000899243-20-029501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000089924320029501/doc4.xml","form_type":"4"}},{"id":3648975,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-19T11:34:29.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of February 15, 2019 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date."}],"balance_after":85000,"derivative":{"exercise_price":5.8,"expiration_date":"2029-02-14","underlying":"Ordinary Shares","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0000899243-19-003972","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000089924319003972/doc4.xml","form_type":"4"}},{"id":3823017,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2018-09-06T17:11:04.000Z","date":"2018-09-04","kind":"purchase","acquired":true,"shares":500,"price":10,"value":5000.0,"ownership":{"direct":true},"balance_after":147958,"source":{"system":"sec-edgar","filing":"0001209191-18-049884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919118049884/doc4.xml","form_type":"4"}},{"id":3831299,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-28T17:18:44.000Z","date":"2018-08-27","kind":"purchase","acquired":true,"shares":500,"price":10,"value":5000.0,"ownership":{"direct":true},"balance_after":147458,"source":{"system":"sec-edgar","filing":"0001209191-18-048708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919118048708/doc4.xml","form_type":"4"}},{"id":3831298,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-28T17:18:44.000Z","date":"2018-08-24","kind":"purchase","acquired":true,"shares":500,"price":10,"value":5000.0,"ownership":{"direct":true},"balance_after":146958,"source":{"system":"sec-edgar","filing":"0001209191-18-048708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919118048708/doc4.xml","form_type":"4"}},{"id":3913730,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Series B-2 Preferred Shares","published_at":"2018-05-30T17:02:40.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":2917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2917},"source":{"system":"sec-edgar","filing":"0001209191-18-034172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919118034172/doc4.xml","form_type":"4"}},{"id":3913729,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Series B-1 Preferred Shares","published_at":"2018-05-30T17:02:40.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":4050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4050},"source":{"system":"sec-edgar","filing":"0001209191-18-034172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919118034172/doc4.xml","form_type":"4"}},{"id":3913728,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Series A Preferred Shares","published_at":"2018-05-30T17:02:40.000Z","date":"2018-05-30","kind":"exercise","acquired":false,"shares":12730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12730},"source":{"system":"sec-edgar","filing":"0001209191-18-034172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919118034172/doc4.xml","form_type":"4"}},{"id":3913727,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-30T17:02:40.000Z","date":"2018-05-30","kind":"purchase","acquired":true,"shares":2000,"price":13,"value":26000.0,"ownership":{"direct":true},"balance_after":146458,"source":{"system":"sec-edgar","filing":"0001209191-18-034172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919118034172/doc4.xml","form_type":"4"}},{"id":3913726,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-30T17:02:40.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":2917,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B-2 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."}],"balance_after":144458,"source":{"system":"sec-edgar","filing":"0001209191-18-034172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919118034172/doc4.xml","form_type":"4"}},{"id":3913725,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-30T17:02:40.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":4050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B-1 Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."}],"balance_after":141541,"source":{"system":"sec-edgar","filing":"0001209191-18-034172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919118034172/doc4.xml","form_type":"4"}},{"id":3913724,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-30T17:02:40.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":12730,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Shares automatically converted into Ordinary Shares of the Issuer on a 1-to-1 basis upon closing of the initial public offering of the Issuer."}],"balance_after":137491,"source":{"system":"sec-edgar","filing":"0001209191-18-034172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919118034172/doc4.xml","form_type":"4"}},{"id":3915041,"issuer":{"id":72802,"kind":"organization","name":"Iterum Therapeutics plc","symbol":"ITRM"},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-29T17:21:50.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":79567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 24, 2018 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date."}],"balance_after":79567,"derivative":{"exercise_price":13,"expiration_date":"2028-05-23","underlying":"Ordinary Shares","underlying_shares":79567},"source":{"system":"sec-edgar","filing":"0001209191-18-033905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553593/000120919118033905/doc4.xml","form_type":"4"}},{"id":4311158,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":72803,"kind":"person","name":"Dunne Michael W.","position":1,"cik":"0001553593","reported_name":"Dunne Michael W.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-22T19:30:19.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":20000,"price":0.49,"value":9800.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":0.49,"exercise_date":"2018-05-18","expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-17-009784","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774917009784/rdgdoc.xml","form_type":"4"}}]}